한글목차

세계의 바이러스학 및 세균학 시장은 2024년에 27억 3,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 6.70%로 성장하여 40억 3,000만 달러에 이를 것으로 예측됩니다.

세계 바이러스학 및 세균학 시장은 바이러스 및 세균 감염증의 이해, 진단, 예방, 치료에 특화된 제품 및 서비스(진단 분석, 백신, 치료 솔루션 등)를 포괄하는 시장입니다. 시장 성장은 주로 감염성 질환의 전 세계적인 확산, 분자진단 기술의 상당한 발전, 항균제 내성의 지속적인 위협에 의해 주도되고 있습니다.

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이러스학 및 세균학 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 기술별(분자진단, 면역측정, 진단 영상, 정보기술)
  • 최종사용자별(병원, 진단센터, 연구기관, 혈액은행)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 바이러스학 및 세균학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이러스학 및 세균학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이러스학 및 세균학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 바이러스학 및 세균학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국

제10장 남미의 바이러스학 및 세균학 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 바이러스학 및 세균학 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Fujirebio Diagnostics Inc.
• Cepheid Inc.
• DiaSorin S.p.A.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Scienion GmbH
• Grifols S.A.
• Qiagen N.V.
• Eiken Chemical Co. Ltd.
• Laboratory Corporation of America Holdings

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

The Global Virology and Bacteriology Market, valued at USD 2.73 Billion in 2024, is projected to experience a CAGR of 6.70% to reach USD 4.03 Billion by 2030. The Global Virology and Bacteriology Market encompasses products and services dedicated to understanding, diagnosing, preventing, and treating viral and bacterial infections, including diagnostic assays, vaccines, and therapeutic solutions. Market growth is principally driven by the increasing global prevalence of infectious diseases, substantial advancements in molecular diagnostics, and the persistent threat of antimicrobial resistance.

Key Market Drivers

The global virology and bacteriology market is significantly influenced by the rising prevalence of infectious diseases, which creates an urgent demand for advanced diagnostic and therapeutic solutions. The continuous emergence and resurgence of pathogens, such as *Mycobacterium tuberculosis*, necessitate sustained public health and clinical intervention efforts. According to the World Health Organization, in November 2024, the Global Tuberculosis Report 2024 highlighted that approximately 8.2 million people were newly diagnosed with tuberculosis globally in 2023, an increase from 7.5 million in 2022, placing it as the leading infectious disease killer. This persistent burden drives the need for novel antimicrobials, efficient vaccines, and rapid diagnostic tools to detect infections and manage outbreaks, stimulating market expansion.

Key Market Challenges

A significant challenging factor impacting the Global Virology and Bacteriology Market is the substantial investment required for developing and commercializing novel antimicrobial agents and advanced diagnostic platforms. This financial barrier directly impedes the ability of companies to allocate sufficient resources towards exploratory research and late-stage clinical trials for new products. The development of innovative solutions, particularly for emerging pathogens and drug-resistant strains, necessitates prolonged research cycles and complex testing, significantly escalating overall expenditure. Such high investment costs can deter smaller companies and limit the portfolio expansion of larger entities, consequently slowing the introduction of much-needed advancements into the market.

Key Market Trends

Artificial Intelligence and Machine Learning are significantly reshaping the global virology and bacteriology market, accelerating drug discovery and enhancing diagnostic precision. These technologies facilitate rapid analysis of vast biological datasets, optimizing therapeutic target identification and drug candidate selection. According to AdvaMed, the medical technology association, a February 2024 report highlighted that over 80% of in-market medical technology products utilizing AI and machine learning perform diagnostic functions, demonstrating their critical role. This integration notably streamlines development timelines and reduces costs. For instance, in October 2025, Insilico Medicine advanced its AI-generated drug, Rentosertib, into Phase IIa clinical trials, underscoring AI's direct impact on novel therapy development.

Key Market Players

• Fujirebio Diagnostics Inc.
• Cepheid Inc.
• DiaSorin S.p.A.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Scienion GmbH
• Grifols S.A.
• Qiagen N.V.
• Eiken Chemical Co. Ltd.
• Laboratory Corporation of America Holdings

Report Scope:

In this report, the Global Virology and Bacteriology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virology and Bacteriology Market, By Technology:

• Molecular Diagnostics
• Immunoassays
• Diagnostic Imaging
• Information Technology

Virology and Bacteriology Market, By End User:

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Blood Banks

Virology and Bacteriology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Virology and Bacteriology Market.

Available Customizations:

Global Virology and Bacteriology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virology and Bacteriology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)
  • 5.2.2. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Blood Banks)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Virology and Bacteriology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virology and Bacteriology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Virology and Bacteriology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Virology and Bacteriology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By End User

7. Europe Virology and Bacteriology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Virology and Bacteriology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By End User
  • 7.3.2. France Virology and Bacteriology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Virology and Bacteriology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Virology and Bacteriology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Virology and Bacteriology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By End User

8. Asia Pacific Virology and Bacteriology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Virology and Bacteriology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By End User
  • 8.3.2. India Virology and Bacteriology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Virology and Bacteriology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Virology and Bacteriology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Virology and Bacteriology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By End User

9. Middle East & Africa Virology and Bacteriology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Virology and Bacteriology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Virology and Bacteriology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Virology and Bacteriology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By End User

10. South America Virology and Bacteriology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Virology and Bacteriology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Virology and Bacteriology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Virology and Bacteriology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Virology and Bacteriology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fujirebio Diagnostics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cepheid Inc.
• 15.3. DiaSorin S.p.A.
• 15.4. Bio-Rad Laboratories Inc.
• 15.5. Thermo Fisher Scientific Inc.
• 15.6. Scienion GmbH
• 15.7. Grifols S.A.
• 15.8. Qiagen N.V.
• 15.9. Eiken Chemical Co. Ltd.
• 15.10. Laboratory Corporation of America Holdings

16. Strategic Recommendations

17. About Us & Disclaimer